Practice
Featured experience
iRhythm Technologies $661.25 million convertible senior notes offering
The 1.5% convertible senior notes are due 2029
Hertz $1 billion financing
We advised Hertz on the transactions
Morgan Stanley $1 billion preferred stock offering
We advised Morgan Stanley on its SEC-registered offering
Snowflake $2.3 billion convertible notes offering and capped call transactions
The convertible senior notes are due 2027 and 2029
Blackhawk Network Holdings, Inc. $500 Million Convertible Notes Offering
Davis Polk advised the joint bookrunning managers in connection with a Rule 144A offering by Blackhawk Network Holdings, Inc…
Belden Inc. Depositary Shares Offering
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered offering of 5,175…
Davis Polk Advises Morgan Stanley on Its $3 Billion Senior Notes Offering
Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $3 billion aggregate principal…
Intercept Pharmaceuticals, Inc. $460 Million Convertible Senior Notes Offering
Davis Polk acted as special product counsel to the representatives of the initial purchasers in connection with an SEC…
Universal American Corp. $115 Million Convertible Senior Notes Offering
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Universal American Corp. of an…
Par Pacific Holdings $100 Million Convertible Senior Notes Offering
Davis Polk advised the representative of the initial purchasers in a Rule 144A offering by Par Pacific Holdings, Inc. of …
Nevro Corp. $172.5 Million Convertible Senior Notes Offering
Davis Polk advised the representatives of the several underwriters, in connection with an SEC-registered offering by Nevro…
The Medicines Company $402.5 Million Convertible Senior Notes Offering
Davis Polk advised the joint bookrunners in connection with a Rule 144A offering by The Medicines Company of $402.5 million…
TimkenSteel Corporation $75 Million Convertible Senior Notes Offering
Davis Polk advised the representative of the underwriters in connection with an SEC-registered offering by TimkenSteel…
Anacor $5.2 billion acquisition by Pfizer
Davis Polk is advising Anacor Pharmaceuticals, Inc. on its approximately $5.2 billion acquisition by Pfizer Inc. The…